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Abstract: Infection following total knee arthroplasty can be difficult to diagnose and treat. Diagnosis is multifactorial and 
relies on the clinical picture, radiographs, bone scans, serologic tests, synovial fluid examination, intra-operative culture 
and histology. Newer techniques including ultrasonication and molecular diagnostic studies are playing an expanded role. 
Two-stage exchange arthroplasty with antibiotic cement and 4-6 weeks of intravenous antibiotic treatment remains the 
most successful intervention for infection eradication. There is no consensus on the optimum type of interval antibiotic 
cement spacer. There is a limited role for irrigation and debridement, direct one-stage exchange, chronic antibiotic 
suppression and salvage procedures like arthrodesis and amputation. We examine the literature on each of the diagnostic 
modalities and treatment options in brief and explain their current significance. 
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  Total knee arthroplasty (TKA) is a common surgery for 
end-stage knee arthritis that is associated with significant 
improvements in pain, function and quality of life. Outcomes 
following TKA are excellent in the majority of the patients. 
Perhaps the most challenging complication following TKA 
is periprosthetic infection (PPI). PPI occurs in 1-2 % of 
primary TKAs and 3-5 % of revision TKAs [1]. It is also 
possible that certain aseptic TKA failures may actually not 
be truly aseptic but secondary to undiagnosed periprosthetic 
infections. An improvement in our ability to diagnose TKA 
infections with more sensitive diagnostic algorithms and 
tests could reveal more PPI than currently estimated [2]. In 
this paper, we review the current literature regarding 
diagnosis and management of PPI in TKA. 
DEFINITION, CLASSIFICATION AND PATHO-
PHYSIOLOGY 
  There is currently no clear consensus on the definition of 
PPI in TKA. A commonly accepted definition was proposed 
by Ghanem et al. as meeting one of the following three 
criteria: 
1.  abscess or sinus tract communicating with the joint 
space; 
2.  a positive pre-op culture of aspirate on solid medium ; 
3.  >2 positive intra-op culture of same organism, or one 
positive culture on solid medium plus gross   
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intracapsular purulence or abnormal histological 
findings (>5 PMNs/HPF) [3]. 
  Based on the timing of the TKA infection, Cui et al. [4] 
classified TKA infections into four types: (1) acute post-
operative (4 weeks post-op); (2) late chronic (indolent 
infection >4 weeks post-operative); (3) acute hematogenous 
(acute onset at the site of a previously well-functioning 
prosthetic joint); and (4) positive intra-operative culture 
(clinically unapparent infection with two or more positive 
intra-operative cultures). 
  TKA infections, like other PPI, are mediated by the 
formation of biofilms on the implant surfaces. Biofilm is an 
aggregate of microorganisms in which cells are adherent to 
each other and/or to a surface. Bacteria secrete extracellular 
polymeric substance (EPS) which forms the basic 
architecture of biofilms [5]. These adherent bacterial cells 
are frequently embedded in small clusters within the EPS 
matrix, often forming favorable environments which can be 
very heterogeneous in the same biofilm. EPS isolates 
bacteria from the surrounding environment and help bacteria 
survive in the biofilm. EPS also protects bacteria from host 
defenses resulting in an ineffective inflammatory response, 
which in turn causes more damage to the host and aids the 
growth of bacteria by providing additional nutrients from 
damaged cells [6, 7]. Antibiotics are ineffective in the non-
physiologic environment of the biofilm due to poor 
penetration. The biofilm itself is responsible for many of the 
challenges underlying diagnosis & management of PPI in 
TKA [8, 9]. 
CLINICAL FEATURES OF INFECTED TKA 
  Infected TKA can present acutely with obvious signs and 
symptoms of joint infection or more insidiously, especially 
beyond the early post-operative period. The clinical signs 
and symptoms of infected TKA include persistent pain, 
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Examination findings include tenderness and limitation of 
range of motion and/or painful range of motion of the joint 
that is new or disproportionate to the expected recovery from 
the surgery. However, PPI in TKA can present with few, if 
any, of these symptoms and signs. 
DIAGNOSIS OF INFECTED TKA 
  The presentation of PPI in TKA can be varied and the 
diagnosis challenging. Because there is no single test that 
can diagnose PPI in TKA, the diagnosis is typically based on 
a combination of clinical, serologic, imaging and laboratory 
findings. 
SEROLOGICAL TESTS 
  The peripheral leukocyte count is frequently normal in 
TKA infections and affords little diagnostic help. 
Erythrocyte sedimentation rate (ESR) is a nonspecific 
indicator of inflammation that peaks 5-7 days after TKA 
surgery and usually returns to baseline in 3 months to 1 year. 
Continued elevation of ESR after TKA is suggestive of 
infection. With an abnormal level defined as >30 mm/hr 3 
months to 1 year after TKA, ESR has a sensitivity of 82% 
and specificity of 87% in diagnosing TKA infections [10]. 
Based on receiver operating curves, a cutoff level of 22.5 
mm/hr 3 months to 1 year after TKA would have sensitivity 
of 93% and specificity of 83%. However, ESR is elevated in 
both inflammatory conditions and infections in locations 
other than infected TKA (10), and thus specificity is low. 
  C - reactive protein (CRP) is an acute phase reactant 
produced by hepatocytes in response to infection, 
inflammation or acute injury. CRP levels peak 2-3 days after 
surgery and return to baseline in 14-21 days. With an 
abnormal level defined as >10 pg/mL 14-21 days after TKA, 
CRP has sensitivity of 93% and specificity 83% [10]. Based 
on receiver operating curves, a cutoff level of 13.5 pg/ml 14-
21 days after TKA, would have sensitivity of 91% and 
specificity of 86% [10]. 
  A new investigational test used in the diagnosis of PPI in 
TKA is serum interleukin-6 (IL-6) level. IL-6 is cytokine 
that stimulates the liver cells to produce acute phase 
reactants like CRP. Serum IL-6 levels can be measured by a 
simple ELISA test. IL-6 levels peak 6-12 hrs after surgery 
and return to baseline in 48-72 hrs. With a cut-off defined as 
<10 pg/mL, IL-6 level has a sensitivity of 100% and a 
specificity of 95% in diagnosing TKA infections [11]. 
However, more studies are needed to examine its clinical 
utility. Other conditions causing elevated serum IL-6 are 
chronic inflammatory diseases like rheumatoid arthritis, 
previous antibiotic treatment prior to surgery, multiple 
sclerosis, Pagets disease of bone and acquired immune 
deficiency syndrome. IL-6 may prove to be useful in early 
post-operative diagnosis of infection and pre-operative 
diagnosis prior to revision total knee arthroplasty [11]. 
IMAGING MODALITIES 
  Several imaging modalities are available to assist 
surgeons in diagnosing PPI in TKA. Radiographs showing 
periosteal new bone formation, scattered foci of osteolysis 
and subchondral bone resorption are highly suggestive of 
infection, but are typically late findings. Periprosthetic 
radiolucency may be unrelated to a septic process and serial 
radiographs help rule out other conditions like wear, 
osteolysis or fracture. 
  Nuclear medicine tests may be helpful in the diagnosis of 
PPI in TKA, because their results are not impacted by the 
presence of metallic implants. Triple-phase technetium-99 
bone scan (TPBS) is a simple, widely available test which is 
quite sensitive in detecting bone remodeling changes around 
TKA components; however, it cannot distinguish between 
aseptic loosening and TKA infection [12]. TPBS does have a 
high negative predictive value, however, making it a useful 
initial screening test [13, 14]. 
  WBC imaging with indium-111 is more sensitive than 
TPBS, but has low specificity. Combining an indium
111 
WBC scan with a technetium
 99m bone scan improves the 
accuracy for detecting deep infection up to 95% [15]. 
  Fluro-deoxyglucose positron emission tomography 
(FDG-PET) scans have been recently evaluated for diagnosis 
of PPI in TKA. Inflammatory cells express more glucose 
transporters, resulting in intracellular accumulation of 
deoxyglucose which cannot be metabolized by the cell and 
can be identified by PET imaging. One study found 91% 
sensitivity and 72% specificity for diagnosis of TKA 
infections [16]. The advantages of a PET scan are that only 
one injection is required and the results are available within 
4 hrs. However, it is not widely available, is expensive and 
can produce false positives secondary to uptake of FDG in 
aseptic inflammation around implants [17]. 
  In their meta-analysis, Reinartz et al. reported that the 
accuracy of the TPBS, WBC imaging, and FDG-PET scan 
was 81%, 84% and 83% respectively [17]. 
JOINT FLUID AND TISSUE ANALYSIS 
  Knee aspiration is a simple test recommended in every 
case of suspected PPI in TKA. The knee aspirate should be 
sent for cell count and differential, culture and crystal 
analysis. Use of antibiotics prior to aspiration can lead to 
false-negative results. In the setting of a 2-stage exchange 
arthroplasty, studies have shown that delaying knee 
aspiration at least 4 weeks from the discontinuation of 
antibiotic therapy can significantly lower the false-negative 
rate [18, 19]. The synovial fluid (SF) leukocyte count and 
differential are two helpful parameters to examine. With an 
abnormal value defined as >1100 WBC/ml, the SF leukocyte 
count has a 91% sensitivity and 88% specificity in 
diagnosing PPI in TKA [3]. With an abnormal value defined 
as >64%, SF neutrophil percentage is 95% sensitive and 94% 
specific in diagnosing TKA infection [3]. If both SF 
leukocyte count and neutrophil percentage, are below their 
cutoff values, then infection is highly unlikely   
(NPV= 98.2%). If both tests are above their cutoff values, 
then the likelihood of infection is 98.6 % (PPV= 98.6%) [3]. 
When SF neutrophil percentage and the C-reactive protein 
level are less than the cutoff values of 64% and 10 mg/L, 
respectively, the presence of periprosthetic infection is very 
unlikely [3]. 
  Intra-operative frozen section looking for neutrophils in 
tissue obtained from the joint capsule or periprosthetic 
membrane has been used to help intra-operative decision 
making. The exact histologic critera used for diagnosis of 
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quoted study [20] found that with abnormal frozen section 
defined as >5 neutrophils /5 separate high power fields 
(500x), excluding surface fibrin and inflammatory exudates, 
the sensitivity is 25% and specificity is 95%. Frozen section 
is less sensitive at the time of reoperation than in the setting 
of primary arthroplasty [20]. 
  Gram staining of intra-operative specimens is not very 
helpful. Morgan et al. [21] found that intra-operative Gram 
staining has poor sensitivity (27%) and a poor negative 
predictive value, and its results did not alter the treatment of 
any patient undergoing revision TKA because of a suspected 
infection. 
 Intra-operative cultures have traditionally been 
considered the gold standard for PPI diagnosis. However, 
nearly 10 % of infections may be culture-negative. 
Conventional culture results may be delayed for 2-5 days 
and contamination of samples causes false positive results 
[2]. 
  It is recommended that pre-operative antibiotics be 
withheld until cultures are obtained, multiple cultures 
including anaerobic cultures be obtained from different sites 
during surgery, fluid be injected directly into culture tubes 
instead of using swabs [22], strict aseptic protocol be 
maintained, and only > 2 positive cultures of same organism 
be regarded as a positive result [2]. 
MOLECULAR DIAGNOSTIC TESTS 
  Molecular diagnostic techniques are new tools in the 
armamentarium for diagnosis of PPI. Polymerase chain 
reaction (PCR) amplifies strains of bacterial DNA to allow 
detection of infectious bacteria. PCR can detect non-viable 
bacteria that do not grow on culture as well as bacteria lysed 
by ultrasonication, with results within 12-13 hrs. Results of 
the PCR are unaffected by the administration of antibiotics. 
However, PCR is exquisitely sensitive; co-amplification of 
contaminating DNA causes false positives mandating strict 
aseptic measures. The specific nature of infection can only 
be identified by comparing DNA sequences with global 
sequence databases and PCR results are not dependable in 
polymicrobial infections [23, 24]. 
  FISH (Fluorescent In Situ Hybridization) utilizes 
fluorescent- labeled oligonucleotide probes that hybridize to 
their intracellular targets permitting single-cell identification 
and quantification by either epifluorescence microscopy or 
flow cytometry. Complex cell envelopes of some bacteria 
may inhibit penetration of the probes. Autofluoresecence of 
some organisms make interpretation difficult [24]. 
  Immunofluorescence microscopy can give results within 
2-3 hrs [24]. The technique is relatively inexpensive 
(excluding the microscope itself) and does not require strict 
aseptic protocol. Immunofluorescence microscopy can 
distinguish between biofilm organisms (large aggregates) 
and contaminants (single dispersed cells/ small aggregates) 
by direct visualization. 
  Biofilm cells of S. aureus and S. epidermidis produce a 
surface epitope (SSPA). SSPA-ELISA test can detect 
antibodies to this epitope. This is a very sensitive and 
specific test in the detection of staphylococcal biofilms (p < 
0.001) [25]. 
  Biofilms are known to be tenacious and difficult to 
dislodge by scraping. Ultrasonication uses ultrasound energy 
to mechanically disrupt biofilm on retrieved implants in 
revision surgery. This increases the number of bacteria 
isolated on culture or other techniques enabling the detection 
of bacteria that would have been missed by conventional 
tissue culture [5, 26]. Sonicate cultures have 78.5% 
sensitivity and 98.8% specificity as compared to 60.8% and 
99.2% for tissue culture. Improvement in sensitivity is 
particularly notable in patients who have been on antibiotics 
within 2 weeks of surgery [5, 26]. 
  Ultrasonication for a longer time (30 min) can lyse the 
bacteria and make them non-viable on cultures. PCR can be 
used to detect these lysed bacteria thereby further improving 
microbiological diagnosis from retrieved implants [5, 26]. 
MANAGEMENT OF INFECTED TOTAL KNEE 
ARTHROPLASTY 
  Treatment of infected TKA is complex, expensive, 
requires more surgical and inpatient time than non-infected 
revision TKA, and is more prone to failure. The goal of 
treatment is eradication of the infection and maintenance of a 
pain-free, functional joint [27]. 
  Treatment options include irrigation and debridement 
with component retention (with or without polyethylene 
exchange), one-stage or two-stage exchange, antibiotic 
suppression, resection arthroplasty and rarely arthrodesis or 
amputation. 
  Irrigation and debridement with component retention 
(with or without polyethylene exchange), is suitable for 
selective cases where infection occurs within the first 4-6 
weeks of primary TKA or in the setting of acute 
hematogenous Gram positive infection with stable implants 
[28, 29]. Polyethylene liner exchange is preferred as it 
allows better debridement of the posterior synovium and 
eliminates biofilm on the polyethylene [30]. Success of open 
debridement with polyethylene exchange is limited (23 to 
28% success rate) by persistence of organisms on retained 
implants, cement and dead bone [31]. Factors associated 
with success include early debridement, absence of sinus 
formation, multiple debridements rather than a single 
debridement, gram positive infection, and use of 4-6 weeks 
of sensitive systemic antibiotics [32-34]. 
 Two-stage  exchange arthroplasty, first described by 
Insall, has been the most successful treatment alterantive for 
infected total knee arthroplaty (91% success rate for 
eradicating infection) [35]. The first stage involves removal 
of all total knee components and cement, thorough 
debridement and irrigation followed by implantation of an 
antibiotic cement depot in the joint. The antibiotic cement 
depot releases antibiotics locally at high concentrations 
helping to eradicate the infection. This is supplemented by 
intravenous antibiotics per sensitivity for six to eight week 
period. If there are no clinical signs of infection and the 
sedimentation rate and CRP levels are declining, a decision 
for second stage reimplantation is made. A more extensile 
approach like quadriceps snip, VY-quadricepsplasty or tibial 
tubercle osteotomy may be necessary because of scarring 
between stages [36]. The second stage involves removal of 
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implantation of appropriate new total knee components with 
antibiotic-impregnated cement. 
  Use of antibiotic-impregnated cement has greatly 
improved the chances of success in treatment of infected 
arthroplasties [37]. Antibiotics suitable for this purpose 
should be heat- stable, broad-spectrum, bactericidal at low 
concentrations, at low risk of allergy /delayed 
hypersensitivity, and available in powder form with low 
serum binding, which facilitates release from the spacer at 
high concentrations for prolonged periods. Antibiotics in 
common usage for this purpose are gentamycin, 
vancomycin, tobramycin and cefuroxime. 
  Antibiotic elution from PMMA depends on the antibiotic 
dose, the combination of antibiotics used, and the type of 
cement [38]. The recommended doses of antibiotics are 2-5 
times higher for therapeutic use than for prophylactic use 
[27]. Most antibiotics have a high initial release followed by 
a reduced, constant, elution over the next several days. 
  A higher dose of gentamicin or tobramycin will increase 
the amount of antibiotic initially released and prolong the 
duration of the bactericidal level of the antibiotic. However, 
higher doses of vancomycin may not increase the in vivo 
elution characteristics [39, 40]. Tobramycin may 
synergistically increase the release of vancomycin in the 
cement mix by “passive opportunism”- a phenomenon that 
one antibiotic dissolves, resulting in increased porosity, it 
allows increased elution of the other antibiotic [39]. 
Tobramycin elutes better from Palacos cement (Heraceus 
Medical, Hanau, Germany; marketed by Zimmer Inc., 
Warsaw, IN) than from Simplex cement (Stryker, 
Kalamazoo, MI). Premixed antibiotic cements have low dose 
of antibiotics [41]. Hand mixing without a vacuum results in 
increased porosity, which increases antibiotic elution. 
  There is an on-going controversy over the optimal type of 
antibiotic spacer to be used. Static spacers, first described by 
Cohen, [42] were historically preformed in the shape of a 
hockey puck that was inserted loosely in the joint space after 
the cement was polymerized. This technique was associated 
with spacer subluxation and secondary bone loss and erosion 
of quadriceps mechanism. This led to the development of the 
molded arthrodesis block. In this technique cement is placed 
in the knee joint in a doughy state so that it conforms to the 
shape of the bone ends and stabilizes the knee joint by 
interdigitation. Static spacers have infection eradication rates 
approximating 88% [43-47]. Static spacers restrict knee 
movement between stages, distract & preserve the joint 
space, provide stability to the limb and give rest to the 
infected joint. Problems with static spacers include 
contracture of the extensor mechanism, collateral ligament 
shortening, arthrofibrosis, tibial and femoral bone loss 
(incidence-60%) and potential difficulty with secondary 
exposure for reimplantation [45,48]. 
 Articulating  spacers maintain joint motion between 
stages and cause less periarticular scarring resulting in easier 
surgical exposure at reimplantation. They result in 
marginally better post-operative ROM and function as 
compared to static spacers, though statistical significance is 
not reached [49]. Infection eradication rates with articulating 
spacers approximate 92% [44, 45, 49-57]. 
  Articulating spacers can be metal on polyethylene (new 
components or recycled components) or cement on cement. 
Cement on cement articulating spacers can be pre-formed or 
manufactured in the operating room with cement molds or 
can be hand-made. Articulating spacers reduce bone loss as 
compared to static spacers [45, 48]. Problems with 
articulating spacers include risk of cement fracture, spacer 
dislocation, and potential problems with wound healing [38]. 
  Cement on cement spacers [45, 49-52] have more surface 
area for antibiotic elution, though these are expensive, take 
more OR time and are prone to cement fracture and 
formation of cement debris [49]. Preformed cement spacers 
(Interspace Knee, Exactech, Gainesville, F) deliver a lower 
dose of single antibiotic [36]. The prosthesis of antibiotic 
loaded acrylic cement (PROSTALAC) (Depuy, Warswaw, 
IN) includes a bicompartmental metal femoral component 
articulating with a polyethylene tibial component. This has a 
91% infection eradication rate but has not yet been approved 
by the US Food and Drug administration [53, 55]. Metal on 
polyethylene spacers [44, 53-57] use a new or recycled 
femoral component and polyethylene insert for articulation. 
This provides an inexpensive articulation that can be custom 
fitted to each patient. However, there is a lower surface area 
for antibiotic elution as compared to cement on cement 
spacers 
 One-stage  exchange involves explantation of all total 
knee components, thorough debridement, copious irrigation 
and reimplantation of new appropriate total knee 
components with antibiotic impregnated cement followed by 
6-12 weeks of systemic antibiotic therapy. This is primarily 
indicated in high morbidity patients unsuitable for multiple 
operations who are infected with susceptible organisms. 
Advantages of one-stage exchange include abbreviated 
recovery and decreased cost and morbidity due to avoidance 
of a second operation. There are few studies published with 
this technique with an average success rate of 81% [58]. One 
of the studies with a higher (89%) success rate [59] found 
that factors associated with success are absence of sinus 
formation, Gram positive infection, use of antibiotic cement 
in reimplantation and 12 weeks of antibiotic therapy. 
Another online publication of 1,000 septic knee revisions at 
the Endo-Klinik in Hamburg over the past 25 years using the 
one-stage revision procedure, the success rate with the one-
stage revision procedure was reported to be 75% 
(http://www.cementinguniversity.com/centres-of-
excellence/endo-klinik/technique/therapy/). 
 Antibiotic  suppression alone is considered only under 
special circumstances because the prognosis for infection 
eradication is poor with only 6% success rate [60]. It may be 
considered if the implant is stable, the microorganism has 
low virulence and is susceptible to oral antibiotics, and the 
patient has a high anesthesia risk [61, 62]. Long term 
antibiotic suppression has a risk of antibiotic related adverse 
effects and emergence of resistant bacteria [62]. 
 Resection  arthroplasty is suitable for low demand 
patients after failure of other treatments in patients with 
polyarticular rheumatoid arthritis. This eradicates infection at 
the cost of stability and function of the knee [63]. 
 Arthrodesis is indicated for infected TKA with deficient 
extensor mechanism and in cases with highly resistant 90    The Open Orthopaedics Journal, 2011, Volume 5  Kalore et al. 
organisms or salvage after failed treatments. Mabry [64] 
found that arthrodesis by intramedullary nailing has a union 
rate of 96% as compared to 67% with external fixation. 
However, the risk of recurrent infection associated with IM 
nailing is 8.3% as compared to 4.9 % with external fixation. 
Infection eradication rates with arthrodesis approach 94%, 
though the complication rate is also very high (40%) [64]. 
  Above knee amputation is considered for life-threatening 
systemic sepsis or persistent local infection combined with 
massive bone loss and intractable pain [30]. The prognosis 
for amputation is poor as more than half of the patients 
become wheelchair-bound [65]. Fortunately, less than 5 % of 
patients with TKA infections need amputation [66]. 
Arthrodesis should be considered early in the treatment of 
persistent infection as multiple revision surgeries may 
ultimately require amputation [67]. 
CONCLUSIONS 
  Periprosthetic TKA infections remain difficult to 
diagnose and treat. Diagnosis is based on a combination of 
clinical findings, serologic tests, and imaging and laboratory 
findings. Knee aspiration for cell count and neutrophil 
differential can be very helpful. Ultrasonication of retrieved 
implants in combination with molecular diagnostic 
techniques is improving our ability to diagnose infections. 
Two stage exchange utilizing antibiotic cement has better 
success at infection eradication than direct exchange. Use of 
an articulating spacer preserves motion between stages and 
reduces scarring and bone loss, with potential improvements 
in ROM, function, and second-stage exposure. Two stage 
exchange with an articulating spacer is the most accepted 
treatment option. 
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